New Study Finds Pfizer Vax 88% Effective Against Delta

The Hill reports:

Two doses of the Pfizer COVID-19 vaccine are 88 percent effective against the delta variant, according to a new study.

The study, published in the New England Journal of Medicine on Wednesday from researchers at Public Health England, offers reassurance about the effectiveness of the vaccines against the delta variant.

The 88 percent effectiveness against the delta variant was only modestly lower than the 93.7 percent effectiveness against the alpha variant, which was first identified in the United Kingdom. The findings reinforce earlier data from Public Health England in May finding 88 percent effectiveness against delta.

Read the full article.

Good news for those concerned about variants impacting vaccine-induced immunity:

Two doses of the Pfizer-BioNTech vaccine were 88% effective in protecting against symptomatic COVID-19 from the SARS-CoV-2 Delta variant, according to a new paper in @NEJM.https://t.co/NXtNMgItFS pic.twitter.com/FjK0YeidhS

— Dr. Rhonda Patrick (@foundmyfitness) July 21, 2021